$PVLA news

The latest PVLA stock news: headlines, filings, AI summaries and sentiment for $PVLA, updated around the clock.

• Palvella Therapeutics Reports Q3 GAAP EPS of -$1.70, Exceeding Estimates Seeking Alpha · November 5, 2026, 19:49 UTC
• Palvella Reports Q3 2026 Financial Results and FDA Priority Review for QTORIN Motley Fool · November 5, 2026, 19:13 UTC
• PALVELLA THERAPEUTICS, INC. - 10-Q Filing SEC EDGAR · November 5, 2026, 13:00 UTC
• PALVELLA THERAPEUTICS, INC. - 8-K Filing SEC EDGAR · November 5, 2026, 12:30 UTC
• FDA Grants Priority Review to Palvella Therapeutics' Qtorin Rapamycin Application Seeking Alpha · October 28, 2026, 15:15 UTC
• PALVELLA THERAPEUTICS, INC. - 8-K Filing SEC EDGAR · October 28, 2026, 11:31 UTC
• Palvella Therapeutics Submits Initial Module of NDA for QTORIN Yahoo Finance · July 15, 2026, 14:01 UTC
• PALVELLA THERAPEUTICS, INC. - 8-K Filing SEC EDGAR · July 14, 2026, 20:49 UTC
• Palvella Therapeutics Insider Sells $476K Worth of Shares Following a 620% Stock Rally Yahoo Finance · June 27, 2026, 16:31 UTC
• Palvella Therapeutics Insider Sells $476K Worth of Shares After Stock Surges Motley Fool · June 27, 2026, 16:11 UTC
• PALVELLA THERAPEUTICS, INC. - 8-K Filing SEC EDGAR · May 20, 2026, 20:36 UTC
• PALVELLA THERAPEUTICS, INC. - 8-K Filing SEC EDGAR · May 13, 2026, 11:30 UTC
• PALVELLA THERAPEUTICS, INC. - 10-Q Filing SEC EDGAR · May 7, 2026, 14:27 UTC